CeleFlux IS CHALLENGING

TREATMENT PARADIGMS IN UROLOGY

OUR VISION:

EXTENDING HEALTHSPAN & RESTORING JOY

 

ABOUT CeleFlux

CeleFlux is a urological medical device company focused on restoring quality of life. 

The company's lead innovation is a urethral stricture treatment system that enables long-lasting minimally invasive reconstruction. This approach bridges the gap between current minimally invasive management options and gold standard definitive open surgical reconstruction - and challenges the clinical paradigm. CeleFlux is based in the Baltimore, Maryland metropolitan area.

 

URETHRAL STRICTURE 

IS A CURABLE CONDITION

TREATED AS A CHRONIC DISEASE

Urethral narrowing makes urination difficult and prevents complete voiding.

The lives of affected men are constantly interrupted by the urgent need to go,
day and night, with a devastating impact on their quality of life.

KEY SYMPTOMS: PAINFUL, FREQUENT URINATION, IMPAIRED SEXUAL INTIMACY, HIGH COMPLICATION RATES

INITIAL SUCCESS OF COMMON MINIMALLY INVASIVE APPROACHES IS ONLY 9%
AFTER 1-3 YEARS 

85-90% OF OPEN RECONSTRUCTION PATIENTS ARE SYMPTOM-FREE

AT 2-4 YEARS

ACCESS TO EXPERTS IN COMPLEX OPEN SURGERY IS LIMITED; SURGERY RECOVERY LENGTHY 2-4 WKS

URETHRAL STRICTURE IS THE MOST COMMON CAUSE OF LUTS IN MEN AGED 20-40

COMMON IN THE ELDERLY POPULATION WITH INCREASING INCIDENCE AFTER 55

NEARLY 1 IN 5 MEN WILL EXPERIENCE A  STRICTURE IN THEIR LIFETIME

LEADS TO 1.5 MILLION OFFICE VISITS ANNUALLY IN THE U.S. ALONE

 

TAURUS by CeleFlux 

MINIMALLY INVASIVELY RECONSTRUCTS

THE URETHRA TO RESTORE URINE FLOW

DEFINITIVELY.

REPAIR THE STRICTURE

END THE CYCLE

CeleFlux has a proof-of-concept prototype currently undergoing preclinical testing.

Contact us to find out more about our results to date, our ongoing development work, or to discuss alignment opportunities.

 

 

THE CeleFlux  TEAM

CeleFlux is an entrepreneurial team of dedicated engineers and clinicians. Our team is proud of its roots - our innovation was born out of the Johns Hopkins Center for Bioengineering Innovation & Design program and further developed at the Johns Hopkins Brady Urological Institute. We are passionate about improving the quality of life of urological patients through the development of paradigm-shifting innovative solutions.  Our strength lies in our diversity. Different people, thinking differently, unified to broadly impact the lives of people across the world.

Chanya Godzich Elakkad

Founder - Business Lead

  • Grey LinkedIn Icon

Chanya is a business-savvy biomedical engineer and entrepreneur. Her professional background includes management, purchasing, and sales experience - obtained prior to pursuing her BS in Bioengineering from UCLA and MSE in Bioengineering Innovation and Design from Johns Hopkins. Chanya leverages this non-traditional combination to bridge the worlds of business, engineering and medicine.

Teja Maruvada

Founder - Tech Lead

  • Grey LinkedIn Icon

Teja is a highly skilled mechanical and biomedical engineer, with over five years of medical device innovation experience. Teja obtained his BEng in Mechanical Engineering from IIT Bombay and his clinically immersive MSE in Bioengineering Innovation and Design from Johns Hopkins. Teja leverages his diverse experience to bridge the gap between technical innovation and clinical application and design.

Dr. E. James Wright

Founder - Clinical Lead

  • Hlogo_edited_edited

Jamie is a world-renown reconstructive urologist, Chief of Urology and Director of Reconstructive and Neurourology at Johns Hopkins Bayview Medical Center. Through his 20+ years of experience treating urethral stricture, he recognized a need for effective minimally invasive repair strategies - lacking a technical solution. Jamie is committed to a bench to bedside approach to innovation and positive impact on patient's lives.

CONTACT US

CeleFlux - learn more or get involved.

We are excited to hear from you!

 

© 2020 by CeleFlux - all rights reserved

Follow Us on Linkedin and Twitter:

  • LinkedIn
  • White Twitter Icon